We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.02%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
-$388M
(-3.6%)
Cap. Flow
-$87.6M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
14.73%
Holding
713
New
186
Increased
183
Reduced
156
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$120M |
| 2 |
Chord Energy
CHRD
|
+$106M |
| 3 |
Electronic Arts
EA
|
+$96.9M |
| 4 |
Quest Diagnostics
DGX
|
+$89.2M |
| 5 |
Sensata Technologies
ST
|
+$76.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$138M |
| 2 |
Avnet
AVT
|
+$130M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$73.5M |
| 5 |
Honeywell
HON
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.43% |
| 2 | Technology | 19.78% |
| 3 | Energy | 7.84% |
| 4 | Industrials | 7.21% |
| 5 | Financials | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
EverCommerce
EVCM
$2.12B
| $3.34M | 0.03% |
304,037
+66,152
| +28% | +$638K |
|
377
Vertiv
VRT
$101B
| $3.31M | 0.03% |
+38,225
| New | +$3.48M |
|
378
Fate Therapeutics
FATE
$291M
| $3.29M | 0.03% |
1,002,002
-890,000
| -47% | -$3.9M |
|
379
Sarepta Therapeutics
SRPT
$1.68B
| $3.22M | 0.03% |
+20,381
| New | +$2.62M |
|
380
DigitalOcean
DOCN
$14.9B
| $3.21M | 0.03% |
+92,284
| New | +$3.28M |
|
381
Jack in the Box
JACK
$324M
| $3.18M | 0.03% |
62,412
-32,745
| -34% | -$1.84M |
|
382
Kulicke & Soffa
KLIC
$4.72B
| $3.18M | 0.03% |
64,617
+32,518
| +101% | +$1.53M |
|
383
Fulcrum Therapeutics
FULC
$283M
| $3.11M | 0.03% |
+501,301
| New | +$3.8M |
|
|
GTHX
384
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.11M | 0.03% |
+1,362,354
| New | +$5.2M |
|
385
Tango Therapeutics
TNGX
$4.43B
| $2.99M | 0.03% |
+348,091
| New | +$2.69M |
|
|
MRSN
386
DELISTED
Mersana Therapeutics
MRSN
| $2.95M | 0.03% |
58,692
-58,693
| -50% | -$4.24M |
|
387
Kura Oncology
KURA
$816M
| $2.95M | 0.03% |
+143,207
| New | +$2.94M |
|
388
Addus HomeCare
ADUS
$2.18B
| $2.88M | 0.03% |
+24,800
| New | +$2.66M |
|
389
Arbutus Biopharma
ABUS
$861M
| $2.86M | 0.03% |
926,534
-3,144,125
| -77% | -$9.43M |
|
390
PepGen
PEPG
$130M
| $2.78M | 0.03% |
+174,036
| New | +$2.49M |
|
391
ImmunityBio
IBRX
$7.49B
| $2.77M | 0.03% |
+437,843
| New | +$2.89M |
|
|
AL
392
DELISTED
Air Lease Corp
AL
| $2.73M | 0.03% |
+57,522
| New | +$2.8M |
|
393
Advanced Drainage Systems
WMS
$11.1B
| $2.69M | 0.03% |
+16,768
| New | +$2.8M |
|
394
Huntington Ingalls Industries
HII
$12.8B
| $2.65M | 0.03% |
10,766
-55,791
| -84% | -$14.5M |
|
395
Replimune Group
REPL
$1B
| $2.64M | 0.03% |
293,622
| – | – |
|
396
Loar Holdings
LOAR
$6.74B
| $2.64M | 0.03% |
+49,353
| New | +$2.67M |
|
|
ATYR
397
aTyr Pharma
ATYR
$48.2M
| $2.63M | 0.03% |
1,683,162
+1,883
| +0.1% | +$3.28K |
|
398
AerCap
AER
$24.2B
| $2.6M | 0.02% |
27,933
-140,463
| -83% | -$12.5M |
|
399
Domo
DOMO
$184M
| $2.57M | 0.02% |
333,467
-53,351
| -14% | -$399K |
|
400
Texas Instruments
TXN
$246B
| $2.52M | 0.02% |
+12,934
| New | +$2.39M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Woodline Partners held 713 positions worth $10.5B, down 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners's Q2 2024 filing shows 186 new, 183 increased, 156 reduced and 168 closed positions. Its largest new stake was Marsh: 585,204 shares worth $123M. The largest sale was Analog Devices, an estimated $138M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Energy.
- Woodline Partners's largest Q2 2024 buy was Marsh: 585,204 shares worth $123M.
- Woodline Partners added most to Chord Energy in Q2 2024, an estimated $106M increase.
- Woodline Partners's biggest Q2 2024 reduction was Avnet, cutting an estimated $130M.
- Woodline Partners fully exited Analog Devices in Q2 2024, selling an estimated $138M.
- Woodline Partners's ten largest holdings make up 15% of its $10.5B portfolio in Q2 2024.
- Woodline Partners opened 186 new positions and closed 168 in Q2 2024.
- Woodline Partners's portfolio value fell 3.6% quarter-over-quarter to $10.5B.
Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.